Business Wire

Digital Workshop: Autodoc Launches the Autodoc Club Innovative Platform

29.10.2019 10:00:00 EET | Business Wire | Press release

Share

Autodoc, the benchmark in the online retailing for car spare parts in Europe, is now offering its customers and interested parties an innovative platform for the maintenance of their own car under the name “Autodoc Club”. Thanks to its features, it is unique on the market. The platform, which is available in 26 European countries, contains over 1,300 professional PDF repair instructions in all national languages, plus 2,240 detailed video tutorials. In addition, there is a whole range of other useful functions, such as the integrated maintenance protocol for your own car. This opens up new possibilities for planning repairs and controlling costs. The Autodoc Club app is scheduled for release for Android and iOS operating systems at the beginning of 2020, and bundles on mobile devices all the Club website functions for smartphone and tablet users.

One-stop shop for advice, service and parts

Autodoc’s “Autodoc Club” now offers its customers an innovative platform that provides a wide range of services related to the repair and maintenance of cars. In addition to instructions in the form of PDFs and video tutorials, Autodoc Club offers various other features: users can not only store their car model in their profile, but also keep a maintenance log, receive reminders for the replacement of consumables or save workshop information.

The main component of the new Autodoc Club is a collection of over 1,300 PDF repair manuals and 2,240 video tutorials on individual repairs. A search function enables the customer to find the right manual for their car for the upcoming project. If a manual is not yet available, it can be requested directly from the Autodoc specialists.

Professional advice and convenient purchase of spare parts

The instructions provide direct access to the Autodoc online shop. The user can order all required parts conveniently in the spare parts dealer’s online shop. If a tool is missing, it can also be ordered directly in the online shop. In case of questions regarding repairs or spare parts, the customer can contact specialists such as car mechanics or technicians directly in the forum at any time. Autodoc Club therefore offers an integrated one-stop solution for car owners who want to repair their car themselves or obtain comprehensive information and buy spare parts directly and inexpensively.

“For the layman, car parts are mostly products that require explanation. From our experience, we know that many customers often have questions and need advice from experts. We now offer such support with the easy-to-use and integrated Autodoc Club platform. Every car owner can see how a repair is done, get help and decide for themselves what support they need from their local workshop. In any case, they can always order parts and tools conveniently from the Autodoc online shop without having to search the Internet for them”, explains Autodoc Managing Director, Alexej Erdle.

Free platform for car-related services

Additional features such as a maintenance log and a reminder function for changing consumables round off the offer and also help to avoid unnecessary costs. As a result, your car always stays in top condition. In the personal area, the user can also store vehicle documents, vehicle insurance policies and their own notes, so that all documents relating to their car are always at hand. And from the beginning of 2020, this will also be possible when on the go and travelling using your smartphone.

The use of the platform is unlimited and independent of placing an order. The creation of a free user account is only required for the personal assistant. Existing registration data for the Autodoc online shop also work on the new portal. Any car data already entered in the store account will also be transferred automatically when registering for Autodoc Club with the same account.

About Autodoc

Autodoc is Europe's leading online dealer for car spare parts. As the fastest-growing company in this sector with sales growth of 63% in the financial year 2018 to around EUR 415 million (2017: EUR 254 million), Autodoc aims to further expand its position. Thanks to its successful expansion, Autodoc is now represented in 25 other European countries in addition to Germany. Autodoc pursues a strong customer focus through social media campaigns, technical support in the respective national language and a current demand-oriented range of almost 2.5 million products from 545 brand manufacturers for 128 car brands. Autodoc GmbH is based in the Berlin district of Lichtenberg and is fully owner-managed. In addition to its headquarters, the company opened a representative office on Kurfürstendamm in May 2019.

The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Thomas Casper
Head of Press and Public Relations & Communication
Tel.: +49-30-2084-78-237
E-mail: t.casper@autodoc.eu
www.autodoc.de

cometis AG
Matthias Kunz
Tel.: +49-611-20-585-564
kunz@cometis.de
www.cometis.de

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye